Jonathan B. Gill, MD
Department of Pediatrics, Division of Pediatrics
Present Title & Affiliation
Primary Appointment
Professor, Department of Pediatrics Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2001 | David Geffen School of Medicine at UCLA, Los Angeles, CA, USA, MD, Medicine |
| 1997 | Harvard University, Cambridge, MA, USA, BA, History and Science |
Postgraduate Training
| 2008-2009 | Special Fellow, Pediatric Hematology and Oncology, Memorial Sloan Kettering Cancer Center and New York Presbyterian/ Weill Cornell, Cornell, NY |
| 2005-2008 | Clinical Fellowship, Pediatric Hematology and Oncology, Memorial Sloan Kettering Cancer Center and New York Presbyterian/ Weill Cornell, Cornell, NY |
| 2001-2005 | Clinical Internship and Residency, Internal Medicine and Pediatrics, Mount Sinai Medical Center, New York, NY |
Board Certifications
| 2009 | Diplomate, American Board of Pediatrics, Hematology and Oncology |
| 2005 | Diplomate, American Board of Pediatrics |
| 2005 | Diplomate, American Board of Internal Medicine |
Experience & Service
Administrative Appointments/Responsibilities
Director, Clinical and Translational Research Program, Department of Pediatrics Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Other Appointments/Responsibilities
Deputy Director of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Zhu C, Olson KA, Roth M, Geller DS, Gorlick RG, Gill J, Laack NN, Randall RL. Provider views on the management of Ewing sarcoma of the spine and pelvis. J Surg Oncol 117(3):417-424, 2018. e-Pub 2017. PMID: 29044582.
- Moody KM, Baker RA, Santizo RO, Olmez I, Spies JM, Buthmann A, Granowetter L, Dulman RY, Ayyanar K, Gill JB, Carroll AE. A randomized trial of the effectiveness of the neutropenic diet versus food safety guidelines on infection rate in pediatric oncology patients. Pediatr Blood Cancer 65(1), 2018. e-Pub 2017. PMID: 28696047.
- Maxwell RR, Egan-Sherry D, Gill JB, Roth ME. Management of chemotherapy-induced febrile neutropenia in pediatric oncology patients: A North American survey of pediatric hematology/oncology and pediatric infectious disease physicians. Pediatr Blood Cancer 64(12), 2017. e-Pub 2017. PMID: 28748605.
- Morris J, Yang R, Roth M, Gill J, Gorlick R, Lo Y, Hoang BH, Garfein E, Geller DS. Mechanical analysis of the vascularized fibular graft prosthetic composite (VFGPC) for internal hemipelvectomy reconstruction. J Surg Oncol 115(7):864-869, 2017. e-Pub 2017. PMID: 28543392.
- Gill J, Connolly P, Roth M, Chung SH, Zhang W, Piperdi S, Hoang B, Yang R, Guzik H, Morris J, Gorlick R, Geller DS. The effect of bone morphogenetic protein-2 on osteosarcoma metastasis. PLoS One 12(3):e0173322, 2017. e-Pub 2017. PMID: 28264040.
- Yang Y, Yang R, Roth M, Piperdi S, Zhang W, Dorfman H, Rao P, Park A, Tripathi S, Freeman C, Zhang Y, Sowers R, Rosenblum J, Geller D, Hoang B, Gill J, Gorlick R. Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model. Genes Cancer 8(1-2):484-494, 2017. PMID: 28435520.
- Cohen B, Roth M, Marron JM, Gray SW, Geller DS, Hoang B, Gorlick R, Janeway KA, Gill J. Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling. Ann Surg Oncol 23(Suppl 5):990-997, 2016. e-Pub 2016. PMID: 27459981.
- Geller DS, Morris J, Revskaya E, Kahn M, Zhang W, Piperdi S, Park A, Koirala P, Guzik H, Hall C, Hoang B, Yang R, Roth M, Gill J, Gorlick R, Dadachova E. Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R). Nucl Med Biol 43(12):812-817, 2016. e-Pub 2016. PMID: 27744117.
- Koirala P, Roth ME, Gill J, Chinai JM, Ewart MR, Piperdi S, Geller DS, Hoang BH, Fatakhova YV, Ghorpade M, Zang X, Gorlick R. HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival. Sci Rep 6:31154, 2016. e-Pub 2016. PMID: 27531281.
- Koirala P, Roth ME, Gill J, Piperdi S, Chinai JM, Geller DS, Hoang BH, Park A, Fremed MA, Zang X, Gorlick R. Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma. Sci Rep 6:30093, 2016. e-Pub 2016. PMID: 27456063.
- Reed DR, Mascarenhas L, Manning K, Hale GA, Goldberg J, Gill J, Sandler E, Isakoff MS, Smith T, Caracciolo J, Lush RM, Juan TH, Lee JK, Neuger AM, Sullivan DM. Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies. Cancer Med 5(2):294-303, 2016. e-Pub 2015. PMID: 26714427.
- Roth M, Barris DM, Piperdi S, Kuo V, Everts S, Geller D, Houghton P, Kolb EA, Hawthorne T, Gill J, Gorlick R. Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma. Pediatr Blood Cancer 63(1):32-8, 2016. e-Pub 2015. PMID: 26305408.
- Geller DS, Gill J, Roth M, Gorlick R. To B(MP-2) or Not To B(MP-2): Cytokines and Tumor Surgery—Letter. Clin Cancer Res 21(17):4022, 2015. PMID: 26330506.
- Geller DS, Singh MY, Zhang W, Gill J, Roth ME, Kim MY, Xie X, Singh CK, Dorfman HD, Villanueva-Siles E, Park A, Piperdi S, Gorlick R. Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2. Clin Cancer Res 21(13):3003-12, 2015. e-Pub 2014. PMID: 25472999.
- Garfein E, Doscher M, Tepper O, Gill J, Gorlick R, Smith RV. Reconstruction of the pediatric midface following oncologic resection. J Reconstr Microsurg 31(5):336-42, 2015. e-Pub 2015. PMID: 25803408.
- Bhattasali O, Vo AT, Roth M, Geller D, Randall RL, Gorlick R, Gill J. Variability in the reported management of pulmonary metastases in osteosarcoma. Cancer Med 4(4):523-31, 2015. e-Pub 2015. PMID: 25626877.
- Poon VI, Roth M, Piperdi S, Geller D, Gill J, Rudzinski ER, Hawkins DS, Gorlick R. Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma. Clin Sarcoma Res 5(1):4, 2015. e-Pub 2015. PMID: 25642322.
- Serrano OK, Knapp E, Huang K, Baran G, Statter M, McClain D, Gill J. Pediatric primary splenic angiosarcoma: an aggressive multidisciplinary approach to the oncologic management of a rare malignancy. World J Surg Oncol 12:379, 2014. e-Pub 2014. PMID: 25487642.
- Gorlick S, Barkauskas DA, Krailo M, Piperdi S, Sowers R, Gill J, Geller D, Randall RL, Janeway K, Schwartz C, Grier H, Meyers PA, Gorlick R, Bernstein M, Marina N. HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. Pediatr Blood Cancer 61(9):1558-64, 2014. e-Pub 2014. PMID: 24753182.
- Roth M, Linkowski M, Tarim J, Piperdi S, Sowers R, Geller D, Gill J, Gorlick R. Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma. Cancer 120(4):548-54, 2014. e-Pub 2013. PMID: 24166473.
- Cao Y, Roth M, Piperdi S, Montoya K, Sowers R, Rao P, Geller D, Houghton P, Kolb EA, Gill J, Gorlick R. Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma. PLoS One 9(8):e106249, 2014. e-Pub 2014. PMID: 25170759.
- Piperdi S, Austin-Page L, Geller D, Ahluwalia M, Gorlick S, Gill J, Park A, Zhang W, Li N, Chung SH, Gorlick R. β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells. Sarcoma 2012:164803, 2012. e-Pub 2012. PMID: 23125530.
- Amrani YM, Gill J, Matevossian A, Alonzo ES, Yang C, Shieh JH, Moore MA, Park CY, Sant'Angelo DB, Denzin LK. The Paf oncogene is essential for hematopoietic stem cell function and development. J Exp Med 208(9):1757-65, 2011. e-Pub 2011. PMID: 21844206.
- Weller E, Long N, Smith A, Williams P, Ravi S, Gill J, Henessey R, Skornik W, Brain J, Kimmel C, Kimmel G, Holmes L, Ryan L. Dose-rate effects of ethylene oxide exposure on developmental toxicity. Toxicol Sci 50(2):259-70, 1999. PMID: 10478863.
Invited Articles
- Weiss A, Gill J, Goldberg J, Lagmay J, Spraker-Perlman H, Venkatramani R, Reed D. Advances in therapy for pediatric sarcomas. Curr Oncol Rep 16(8):395, 2014. PMID: 24894064.
- Gill J, Ahluwalia MK, Geller D, Gorlick R. New targets and approaches in osteosarcoma. Pharmacol Ther 137(1):89-99, 2013. PMID: 22983152.
- Gill J. Inherited hematologic and oncologic syndromes. Pediatr Rev 32(9):401-4; discussion 404, 2011. PMID: 21885666.
Editorials
- Gill J, Gorlick R. Sarcomas With Complex Genetic Changes. Oncology Times 38(17):1,6,10-10, 2016.
Book Chapters
- Geller DS, Gill J, Thornhill BA, Spierer M, Gorlick R. Osteosarcoma: A Multidisciplinary Approach. In: Sarcoma Oncology: A Multidisciplinary Approach. PMPH-USA, 2015.
- Gill J, Geller D, Gorlick R. HER-2 involvement in osteosarcoma. In: Adv Exp Med Biol, 161-77, 2014.
- Gill J, Geller D, Gorlick R. Personalized medicine and targeted therapy for osteosarcoma. In: Principles of Molecular Diagnostics and Personalized Cancer Medicine. Lippincott, Williams & Wilkins: Philadelphia, 900-908, 2013.
Patient Reviews
CV information above last modified March 28, 2024